Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Gigascience ; 132024 Jan 02.
Article in English | MEDLINE | ID: mdl-38837946

ABSTRACT

BACKGROUND: Theobroma grandiflorum (Malvaceae), known as cupuassu, is a tree indigenous to the Amazon basin, valued for its large fruits and seed pulp, contributing notably to the Amazonian bioeconomy. The seed pulp is utilized in desserts and beverages, and its seed butter is used in cosmetics. Here, we present the sequenced telomere-to-telomere genome of cupuassu, disclosing its genomic structure, evolutionary features, and phylogenetic relationships within the Malvaceae family. FINDINGS: The cupuassu genome spans 423 Mb, encodes 31,381 genes distributed in 10 chromosomes, and exhibits approximately 65% gene synteny with the Theobroma cacao genome, reflecting a conserved evolutionary history, albeit punctuated with unique genomic variations. The main changes are pronounced by bursts of long-terminal repeat retrotransposons at postspecies divergence, retrocopied and singleton genes, and gene families displaying distinctive patterns of expansion and contraction. Furthermore, positively selected genes are evident, particularly among retained and dispersed tandem and proximal duplicated genes associated with general fruit and seed traits and defense mechanisms, supporting the hypothesis of potential episodes of subfunctionalization and neofunctionalization following duplication, as well as impact from distinct domestication process. These genomic variations may underpin the differences observed in fruit and seed morphology, ripening, and disease resistance between cupuassu and the other Malvaceae species. CONCLUSIONS: The cupuassu genome offers a foundational resource for both breeding improvement and conservation biology, yielding insights into the evolution and diversity within the genus Theobroma.


Subject(s)
Evolution, Molecular , Genome, Plant , Phylogeny , Chromosomes, Plant , Genomics/methods , Malvaceae/genetics
2.
Environ Sci Process Impacts ; 25(4): 781-790, 2023 Apr 26.
Article in English | MEDLINE | ID: mdl-37005869

ABSTRACT

High levels of reactive chemicals may be emitted to the indoor air during household surface cleaning, leading to poorer air quality and potential health hazards. Hydrogen peroxide (H2O2)-based cleaners have gained popularity in recent years, especially in times of COVID-19. Still, little is known regarding the effects of H2O2 cleaning on indoor air composition. In this work we monitored time-resolved H2O2 concentrations during a cleaning campaign in an occupied single-family residence using a cavity ring-down spectroscopy (CRDS) H2O2 analyzer. During the cleaning experiments, we investigated how unconstrained (i.e., "real-life") surface cleaning with a hydrogen peroxide solution influenced the indoor air quality of the house, and performed controlled experiments to investigate factors that could influence H2O2 levels including surface area and surface material, ventilation, and dwell time of the cleaning solution. Mean peak H2O2 concentrations observed following all surface cleaning events were 135 ppbv. The factors with the greatest effect on H2O2 levels were distance of the cleaned surface from the detector inlet, type of surface cleaned, and solution dwell time.


Subject(s)
Air Pollution, Indoor , COVID-19 , Humans , Hydrogen Peroxide , Air Pollution, Indoor/analysis , Housing , Ventilation
3.
J Sep Sci ; 43(7): 1232-1239, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31926120

ABSTRACT

Salicylic acid is an emerging environmental contaminant, usually found at ng/L concentrations in natural waters. Its quantification usually involves liquid chromatography-tandem mass spectrometry, which requires complex and costly instrumentation as well as time-consuming sample pretreatment, typically involving large solvent volumes. In this work, sequential injection chromatography was exploited to develop a fast, green, cost-effective, and highly sensitive procedure for fluorimetric determination of salicylic acid in natural waters. Analyte preconcentration directly on the chromatographic column (on-column preconcentration) was exploited to improve detectability, yielding an enrichment factor of 122 (1.75 mL of sample) and takes only 8.5 min per determination. A detection limit of 20 ng/L, a linear response range from 0.06 to 5.00 µg/L, coefficients of variation lower than 3.0% (n = 10), and recoveries within 86 and 114% were estimated. The procedure was applied for the analyses of freshwater samples and results agreed with those obtained by liquid chromatography-tandem mass spectrometry at the 95% confidence level. The proposed procedure encompasses in-line concentration, isolation/separation, and detection, without the need for sample clean-up, thus minimizing the consumption of organic solvents and risk of analyte losse.


Subject(s)
Environmental Pollutants/analysis , Fresh Water/chemistry , Salicylic Acid/analysis , Water Pollutants, Chemical/analysis , Fluorometry
4.
Curr Eye Res ; 39(1): 99-102, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24325382

ABSTRACT

PURPOSE: To evaluate the in vivo release and ocular toxicity of a tacrolimus-loaded PLGA intravitreal implant. METHODS: Tacrolimus-loaded PLGA implants were inserted into the vitreous cavity of rabbits' eye. At different time points, the vitreous was retrieved and the concentration of tacrolimus released from the implants was determined. Clinical examination was performed to evaluate the implant tolerance. RESULTS: PLGA implants provided controlled and prolonged release of tacrolimus. Approximately 99.97% of the drug was released from the devices at 6 weeks. Ophthalmic examination revealed no evidence of toxic effects of implants. CONCLUSIONS: Tolerance and feasibility of the tacrolimus-loaded PLGA implants, as sustained intraocular drug delivery systems, were demonstrated.


Subject(s)
Lactic Acid/toxicity , Polyglycolic Acid/toxicity , Prostheses and Implants/adverse effects , Tacrolimus/toxicity , Uveitis/drug therapy , Animals , Biocompatible Materials/pharmacology , Biocompatible Materials/toxicity , Choroid/drug effects , Drug Delivery Systems/adverse effects , Feasibility Studies , Female , Immunosuppressive Agents/pharmacology , Immunosuppressive Agents/toxicity , Intravitreal Injections , Polylactic Acid-Polyglycolic Acid Copolymer , Rabbits , Retina/drug effects , Sclera/drug effects , Tacrolimus/pharmacology , Vitreous Body/drug effects
5.
J Drug Target ; 21(9): 837-45, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23952807

ABSTRACT

PURPOSE: To evaluate the in vivo release, retinal safety and antiangiogenic effect of a thalidomide-loaded poly-lactide-co-glycolide intravitreal implant. METHODS: New Zealand white rabbits, divided into two groups, I and II, received an intravitreal implant containing or not thalidomide, respectively (n = 12). Intravitreal drug levels were determined during a six-week study period. The potential for toxicity associated with the implants was evaluated by electroretinography and light microscopy (n = 8). Twelve chorioallantoic membranes (CAMs) from chicken eggs were incubated with thalidomide dispersion, implants containing or not thalidomide and vitreous samples and analyzed after two days regarding the percentage of vessels regression. RESULTS: Intravitreal concentrations of thalidomide (ng/ml) were 690.21 ± 177.95, 372.51 ± 185.56, 240.59 ± 133.48, 327.54 ± 169.71, 294.26 ± 142.41 and 465.18 ± 157.51 at 1, 2, 3, 4, 5 and 6 weeks, respectively, after implantation in group I rabbits. No drug was detected in group II samples. Electroretinography and histological evaluations did not show any sign of retina toxicity. There was significant regression of vessels in CAM incubated with thalidomide dispersion, thalidomide-loaded implants and vitreous samples from group I when compared to control. CONCLUSION: The intravitreal implants delivered safe doses of thalidomide that were also effective to induce vessels regression in CAMs.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Chorioallantoic Membrane/drug effects , Retina/drug effects , Thalidomide/administration & dosage , Vitreous Body/drug effects , Angiogenesis Inhibitors/adverse effects , Angiogenesis Inhibitors/pharmacokinetics , Angiogenesis Inhibitors/pharmacology , Animals , Chick Embryo , Chorioallantoic Membrane/blood supply , Drug Implants , Electroretinography , Female , Rabbits , Retina/pathology , Solubility , Thalidomide/adverse effects , Thalidomide/pharmacokinetics , Thalidomide/pharmacology , Vitreous Body/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...